JPWO2022150485A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022150485A5 JPWO2022150485A5 JP2023541041A JP2023541041A JPWO2022150485A5 JP WO2022150485 A5 JPWO2022150485 A5 JP WO2022150485A5 JP 2023541041 A JP2023541041 A JP 2023541041A JP 2023541041 A JP2023541041 A JP 2023541041A JP WO2022150485 A5 JPWO2022150485 A5 JP WO2022150485A5
- Authority
- JP
- Japan
- Prior art keywords
- lnp
- lipid
- item
- peg
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163134376P | 2021-01-06 | 2021-01-06 | |
| US63/134,376 | 2021-01-06 | ||
| US202163147959P | 2021-02-10 | 2021-02-10 | |
| US63/147,959 | 2021-02-10 | ||
| US202163181917P | 2021-04-29 | 2021-04-29 | |
| US202163181663P | 2021-04-29 | 2021-04-29 | |
| US202163181899P | 2021-04-29 | 2021-04-29 | |
| US63/181,899 | 2021-04-29 | ||
| US63/181,663 | 2021-04-29 | ||
| US63/181,917 | 2021-04-29 | ||
| PCT/US2022/011450 WO2022150485A1 (en) | 2021-01-06 | 2022-01-06 | Encapsulated rna polynucleotides and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024503623A JP2024503623A (ja) | 2024-01-26 |
| JPWO2022150485A5 true JPWO2022150485A5 (https=) | 2025-02-03 |
| JP2024503623A5 JP2024503623A5 (https=) | 2025-02-03 |
Family
ID=82357635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541041A Pending JP2024503623A (ja) | 2021-01-06 | 2022-01-06 | カプセル化ｒｎａポリヌクレオチド及び使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240115636A1 (https=) |
| EP (1) | EP4274591A4 (https=) |
| JP (1) | JP2024503623A (https=) |
| KR (1) | KR20230143141A (https=) |
| AU (1) | AU2022206676A1 (https=) |
| CA (1) | CA3204244A1 (https=) |
| WO (1) | WO2022150485A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023091490A1 (en) * | 2021-11-16 | 2023-05-25 | Senda Biosciences, Inc. | Novel ionizable lipids and lipid nanoparticles and methods of using the same |
| WO2023223183A1 (en) * | 2022-05-16 | 2023-11-23 | Crispr Therapeutics Ag | Picornaviral vectors for gene editing |
| WO2024031078A2 (en) * | 2022-08-05 | 2024-02-08 | Elevatebio Technologies, Inc. | Chimeric oncolytic viruses with tropism for poliovirus receptor |
| EP4612284A2 (en) | 2022-11-04 | 2025-09-10 | Life Edit Therapeutics, Inc. | Evolved adenine deaminases and rna-guided nuclease fusion proteins with internal insertion sites and methods of use |
| WO2024162304A1 (ja) | 2023-01-31 | 2024-08-08 | アステラス製薬株式会社 | 環状アミンを有するカルバモイル脂質又はウレア脂質、それを含む脂質ナノ粒子、及び医薬組成物 |
| WO2024178397A2 (en) | 2023-02-24 | 2024-08-29 | Elevatebio Technologies, Inc. | Modified immune effector cells and methods of use |
| WO2024226832A1 (en) * | 2023-04-25 | 2024-10-31 | Orgenesis Inc. | Ribonucleases for treating viral infections |
| WO2025022367A2 (en) | 2023-07-27 | 2025-01-30 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
| WO2025083619A1 (en) | 2023-10-18 | 2025-04-24 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and acive fragments and variants thereof and methods of use |
| TW202546224A (zh) | 2024-02-12 | 2025-12-01 | 美商生命編輯治療學公司 | 新穎的ｒｎａ引導之核酸酶及用於聚合酶編輯之蛋白質 |
| WO2026003754A1 (en) | 2024-06-25 | 2026-01-02 | Life Edit Therapeutics, Inc. | Novel reverse transcriptases and uses thereof |
| WO2026006491A1 (en) * | 2024-06-25 | 2026-01-02 | Cornell University | Senecavirus a (sva) vaccine compositions and methods thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006074526A1 (en) * | 2005-01-17 | 2006-07-20 | Viralytics Limited | Method and composition for treatment of neoplasms |
| HRP20220652T1 (hr) * | 2015-12-10 | 2022-06-24 | Modernatx, Inc. | Pripravci i postupci unosa terapijskih sredstava |
| AU2018301701A1 (en) * | 2017-07-14 | 2020-02-27 | Elevatebio Technologies, Inc. | Encapsulated polynucleotides and methods of use |
| WO2019046809A1 (en) * | 2017-08-31 | 2019-03-07 | Modernatx, Inc. | METHODS OF MANUFACTURING LIPID NANOPARTICLES |
| WO2019210394A1 (en) * | 2018-04-29 | 2019-11-07 | Precision Nanosystems Inc. | Compositions for transfecting resistant cell types |
| EP3906039A4 (en) * | 2019-01-04 | 2023-01-18 | Oncorus, Inc. | ENCAPSULATED POLYNUCLEOTIDES AND METHODS OF USE |
| EP3956459A4 (en) * | 2019-04-15 | 2023-01-11 | Precision Nanosystems Inc | NONVIRAL MODIFICATION OF T LYMPHOCYTE GENE EXPRESSION |
-
2022
- 2022-01-06 AU AU2022206676A patent/AU2022206676A1/en active Pending
- 2022-01-06 EP EP22737107.7A patent/EP4274591A4/en not_active Withdrawn
- 2022-01-06 WO PCT/US2022/011450 patent/WO2022150485A1/en not_active Ceased
- 2022-01-06 KR KR1020237026655A patent/KR20230143141A/ko active Pending
- 2022-01-06 JP JP2023541041A patent/JP2024503623A/ja active Pending
- 2022-01-06 CA CA3204244A patent/CA3204244A1/en active Pending
- 2022-01-06 US US18/260,375 patent/US20240115636A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications | |
| JPWO2020142725A5 (https=) | ||
| US9890391B2 (en) | RNA vector with an open reading frame, an albumin 3′-UTR, and a histone stem loop | |
| JPWO2022150485A5 (https=) | ||
| JP2024167285A (ja) | カプセル化ポリヌクレオチド及び使用方法 | |
| JP2024503623A (ja) | カプセル化ｒｎａポリヌクレオチド及び使用方法 | |
| TW201936201A (zh) | 基因之非病毒生產及遞送 | |
| CN116949050A (zh) | mRNA的功能化方法 | |
| CA3143627A1 (en) | Carbohydrate nanocarrier delivery of hepatitis b virus (hbv) vaccines | |
| KR102948789B1 (ko) | 항원 제시 세포를 표적으로 하는 지질 조성물 및 이의 용도 | |
| Qu et al. | Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons | |
| CN119074950A (zh) | 一种增强mRNA-LNP组织靶向递送的方法 | |
| Yang et al. | Advancing cancer treatment: in vivo delivery of therapeutic small noncoding RNAs | |
| JPWO2021243172A5 (https=) | ||
| JP2004175665A (ja) | タンパク質中空ナノ粒子およびそれを用いた薬剤 | |
| CN113660938A (zh) | 核酸递送复合物 | |
| WO2025016031A1 (zh) | 自扩增核酸分子及其应用 | |
| CN115141846B (zh) | 一种双启动子质粒及其构建方法和应用 | |
| KR20240072931A (ko) | 히스티딘을 포함하는 지질 나노입자 및 그 제조방법 | |
| JP7575761B2 (ja) | 核酸封入ａａｖ中空粒子の製造方法 | |
| CN117568338A (zh) | 一种优化的polyA序列及其应用 | |
| Zhen et al. | Unlocking the potential of engineered circular RNA therapeutics | |
| JPWO2020102285A5 (https=) | ||
| Penumarthi et al. | Hitching a ride: enhancing nucleic acid delivery into target cells through nanoparticles | |
| KR20220005411A (ko) | 질환 세포-특이적인 miRNA에 의해 세포 생리 활성 조절 물질의 활성을 조절하는 복합체 및 이를 CRISPR/Cas 시스템에 적용한 질환 특이적 유전자 조작용 복합체 |